LUPPI, Mario
 Distribuzione geografica
Continente #
NA - Nord America 52.551
AS - Asia 24.779
EU - Europa 22.739
SA - Sud America 3.443
AF - Africa 592
OC - Oceania 79
Continente sconosciuto - Info sul continente non disponibili 49
Totale 104.232
Nazione #
US - Stati Uniti d'America 51.733
SG - Singapore 7.108
GB - Regno Unito 7.070
CN - Cina 6.832
IT - Italia 4.483
HK - Hong Kong 3.879
VN - Vietnam 2.648
BR - Brasile 2.629
SE - Svezia 2.256
DE - Germania 1.887
FI - Finlandia 1.797
RU - Federazione Russa 1.110
UA - Ucraina 920
FR - Francia 908
TR - Turchia 809
KR - Corea 781
NL - Olanda 617
IN - India 559
ID - Indonesia 435
BG - Bulgaria 405
CA - Canada 404
BD - Bangladesh 290
AR - Argentina 279
MX - Messico 225
IQ - Iraq 201
JP - Giappone 199
ES - Italia 161
IE - Irlanda 157
ZA - Sudafrica 155
PL - Polonia 141
EC - Ecuador 133
PK - Pakistan 133
AE - Emirati Arabi Uniti 123
BE - Belgio 120
AT - Austria 116
CO - Colombia 106
CZ - Repubblica Ceca 105
LT - Lituania 91
MA - Marocco 87
VE - Venezuela 79
CL - Cile 78
PH - Filippine 77
AU - Australia 74
IR - Iran 68
UZ - Uzbekistan 67
KE - Kenya 66
SA - Arabia Saudita 64
BZ - Belize 58
MY - Malesia 58
TN - Tunisia 53
DZ - Algeria 52
JO - Giordania 52
PY - Paraguay 52
EG - Egitto 51
AZ - Azerbaigian 41
TW - Taiwan 40
RO - Romania 39
CH - Svizzera 36
TH - Thailandia 36
IL - Israele 34
NP - Nepal 34
EU - Europa 33
DK - Danimarca 31
PE - Perù 31
SI - Slovenia 31
PT - Portogallo 28
BO - Bolivia 27
UY - Uruguay 27
JM - Giamaica 26
OM - Oman 26
RS - Serbia 26
CR - Costa Rica 25
SK - Slovacchia (Repubblica Slovacca) 25
AL - Albania 24
ET - Etiopia 23
QA - Qatar 23
NO - Norvegia 21
DO - Repubblica Dominicana 20
GR - Grecia 20
HU - Ungheria 19
KZ - Kazakistan 19
CY - Cipro 17
BY - Bielorussia 16
LB - Libano 16
KG - Kirghizistan 15
NG - Nigeria 15
PS - Palestinian Territory 15
PA - Panama 14
MK - Macedonia 13
SN - Senegal 13
BH - Bahrain 12
LV - Lettonia 12
EE - Estonia 11
HR - Croazia 11
BN - Brunei Darussalam 10
LU - Lussemburgo 10
MD - Moldavia 10
NI - Nicaragua 10
XK - ???statistics.table.value.countryCode.XK??? 10
AM - Armenia 9
Totale 104.045
Città #
Fairfield 5.249
Ashburn 5.217
Southend 4.804
Santa Clara 4.534
Singapore 4.402
Hong Kong 3.749
Woodbridge 3.230
Houston 2.615
Chandler 2.612
Hefei 2.360
Seattle 1.992
San Jose 1.773
Ann Arbor 1.769
Wilmington 1.757
Jacksonville 1.736
Cambridge 1.664
Dearborn 1.402
Helsinki 1.373
Nyköping 1.251
London 1.221
Beijing 1.104
Los Angeles 955
Chicago 904
Ho Chi Minh City 854
Modena 824
New York 756
Seoul 737
The Dalles 705
Council Bluffs 650
Hanoi 601
San Diego 502
Buffalo 449
Princeton 431
Izmir 424
Milan 409
Sofia 393
Lauterbourg 364
Salt Lake City 333
Eugene 319
Amsterdam 316
Munich 316
Dallas 315
Moscow 309
Jakarta 305
Shanghai 254
Bologna 246
São Paulo 225
Rome 174
Fremont 172
Bremen 161
Orem 159
Da Nang 156
Des Moines 155
Tampa 155
Columbus 153
Frankfurt am Main 153
Dublin 143
Elk Grove Village 132
Tokyo 129
Boardman 126
Redwood City 114
Phoenix 111
Haiphong 110
Guangzhou 105
Nuremberg 104
Toronto 104
Warsaw 103
Kent 101
Turku 97
Brooklyn 96
Montreal 96
Atlanta 95
Philadelphia 94
Boston 88
Utrecht 83
Chennai 81
Rio de Janeiro 81
Denver 80
Reggio Emilia 80
Johannesburg 75
Mexico City 74
Brussels 73
Falls Church 71
Baghdad 70
Las Vegas 70
Stockholm 69
Redondo Beach 65
Lancaster 64
Norwalk 64
Miami 62
San Francisco 62
Vienna 61
Kilburn 60
Nairobi 60
Tashkent 60
Mumbai 59
Belize City 58
Nanjing 58
Parma 58
Sterling 57
Totale 73.851
Nome #
Retinoic acid and arsenic trioxide for acute promyelocytic leukemia. 931
Monocytic population in chronic lymphocytic leukemia shows altered composition and deregulation of genes involved in phagocytosis and inflammation 586
Clinical Utility of Epstein-Barr Virus Viral Load Monitoring and Risk Factors for Posttransplant Lymphoproliferative Disorders After Kidney Transplantation 463
HHV-6A in syncytial giant-cell hepatitis 460
Changes in T-Cell Responses Against Human Herpesvirus-8 Correlate with the Disease Course of Iatrogenic Kaposi's Sarcoma in a Patient with Undifferentiated Arthritis 441
Feedbacks and adaptive capabilities of the PI3K/Akt/mTOR axis in acute myeloid leukemia revealed by pathway selective inhibition and phosphoproteome analysis 438
Characterization of Specific Immune Responses to Different Aspergillus Antigens during the Course of Invasive Aspergillosis in Hematologic Patients 417
Lack of confirmation of an association between HTLV-I infection and myelodysplastic syndrome 407
Kaposi's sarcoma after liver transplantation 406
Acquired haemophilia in HIV negative, HHV-8 positive multicentric Castleman's disease: a case report 400
Abstracts from the 55th European Society of Human Genetics (ESHG) Conference: Hybrid Posters 399
Epidemiology and clinical outcome of lower respiratory tract infections by respiratory syncytial virus or parainfluenza virus type 3 in adults receiving treatment for either acute leukemia or severe aplastic anemia: a retrospective single center study 399
B cells and herpesviruses: a model of lymphoproliferation 397
Performance of tests for latent tuberculosis in different groups of immunocompromised patients 394
BCR-ABL-specific T-cell therapy in Ph+ ALL patients on tyrosine-kinase inhibitors 391
The expression of endothelin-1 in chronic lymphocytic leukemia is controlled by epigenetic mechanisms and extracellular stimuli. 388
Helicobacter pylori infection andchronic immune thrombocytopenic purpura: long-term results of bacteriumeradication and association with bacterium virulence profiles 388
Idelalisib impairs T-cell-mediated immunity in chronic lymphocytic leukemia 368
An unusual case of B-ALL occurring in a patient with acute promyelocytic leukemia in remission after two hematopoietic SCTs: whose are the leukemic cells? 367
Bone marrow failure associated with human herpesvirus 8 infection after transplantation 363
Herpes Simplex re-activation in patients with SARS-CoV2 pneumonia: a prospective observational study. 362
NPM1 mutations may reveal acute myeloid leukemia in cases otherwise morphologically diagnosed as myelodysplastic syndromes or myelodysplastic/myeloproliferative neoplasms 360
Diagnosis of occult tuberculosis in hematological malignancy by enumeration of antigen-specific T cells. 355
Selective inhibition of PI3Kγ affects survival and proliferation of chronic lymphocytic leukemia B cells 355
Acute myeloid leukemia in patients living with HIV infection: Several questions, fewer answers 355
Acute appendicitis in adult neutropenic patients with hematologic malignancies 354
Post-transplant Kaposi sarcoma originates from the seeding of donor-derived progenitors 353
Reversal of the glycolytic phenotype of primary effusion lymphoma cells by combined targeting of cellular metabolism and PI3K/Akt/ mTOR signaling 353
Human herpesvirus-8 DNA sequences in Human Immunodeficiency Virus-negative angioimmunoblastic lymphadenopathy and benign lymphadenopathy with giant germinal center hyperplasia and increased vascularity 352
A hematology consensus agreement on antifungal strategies for neutropenic patients with hematological malignancies and stem cell transplant recipients 351
A case of JAK2 V617F-positive myelodysplastic/myeloproliferative neoplasm with unusual morphology, resembling acute promyelocytic leukemia-like disorder with a chronic course. 350
PCR con primer degenerati non evidenzia sequenze virali di HHV-8 ne di una sua variante in cellule stromali midollari di pazienti affetti da gammopatie monoclonali 350
Detection of Pneumocystis jirovecii and Aspergillus spp. DNa in bronchoalveolar lavage fluids by commercial real-time PCr assays: comparison with conventional diagnostic tests 348
Complessazione di SiRNA anti Blimp-1/PRDM con liposomi cationici: caratterizzazione chimico-fisica e validazione in vitro su cellule di PEL 347
Ibrutinib modifies the function of monocyte/macrophage population in chronic lymphocytic leukemia 347
Emergence of BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph+ acute lymphoblastic leukemia during long-term Imatinib mesylate treatment. 347
Early versus delayed palliative/supportive care in advanced cancer: An observational study 344
PEGylated siRNA lipoplexes for silencing of BLIMP-1 in Primary Effusion Lymphoma: In vitro evidences of antitumoral activity 342
Characterization and dynamics of specific T cells against nucleophosmin-1 (NPM1)-mutated peptides in patients with NPM1-mutated acute myeloid leukemia 342
Detection of Fusarium-specific T cells in hematologic patients with invasive fusariosis 341
Assessment of aspergillus-specific T cells for diagnosis of invasive aspergillosis in a leukemic child with liver lesions mimicking hepatosplenic candidiasis 341
Cidofovir-loaded liposomes: an intro-study using BCBL-1 cell line as a model for primary effusion lymphoma 340
Leukaemic pulmonary infiltrates in adult acute myeloid leukaemia: a high-resolution computerized tomography study 340
Antineoplastic effects of liposomal siRNA treatment targeting BLIMP1/PRDM1 in primary effusion lymphoma 340
Translational challenges of human herpesvirus 6 chromosomal integration. 338
Novel polymeric/lipidic hybrid systems (PLHs) for effective Cidofovir delivery: preparation, characterization and comparative in vitro study with polymeric particles and liposomes 338
Chronic myeloid leukemia with thrombocythemic onset may be associated with different BCR/ABL variant transcripts 337
From gating to computational flow cytometry: Exploiting artificial intelligence for MRD diagnostics 336
Changes in the immune responses against human herpesvirus-8 in the disease course of posttransplant Kaposi sarcoma 334
Effectiveness of originator (Neupogen) and biosimilar (Zarzio) filgrastim in autologous peripheral blood stem cell mobilization in adults with acute myeloid leukemia: a single-center retrospective study 332
An unusual case of splenomegaly and increased lactate dehydrogenase heralding acute myeloid leukemia with eosinophilia and RUNX1-MECOM fusion transcripts 331
Evaluation of serum (1 → 3)-β-D-glucan clinical performance: kinetic assessment, comparison with galactomannan and evaluation of confounding factors 330
Increased SHISA3 expression characterizes chronic lymphocytic leukemia patients sensitive to lenalidomide 328
Mucorales-specific T cells in patients with hematologic malignancies 326
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through eta receptor 324
Diagnosis of invasive aspergillosis by tracking Aspergillus-specific T cells in hematologic patients with pulmonary infiltrates 323
Immunophenotypic Profile and Clinical Outcome of Monoclonal B-cell Lymphocytosis in Kidney Transplantation 322
Monocyte Distribution Width (MDW) as novel inflammatory marker with prognostic significance in COVID-19 patients 321
A t(11;20)(p15;q11) may identify a subset of nontherapy-related acute myelocytic leukemia 319
Ocular involvement as first sign of isolated CNS relapse in diffuse large B-cell lymphoma 319
Chronic eosinophilic leukaemia with ETV6-NTRK3 fusion transcript in an elderly patient affected with pancreatic carcinoma 318
Atraumatic splenic rupture in patients with myelodysplastic syndromes: Report of a case occurred during treatment with 5-azacitidine and review of the literature. 318
Long-term salvage therapy with cyclosporin A in refractory idiopathic thrombocytopenic purpura. 317
Pathogenetic mechanisms of hepatitis C virus-induced B-cell lymphomagenesis. 317
Physical contact with endothelial cells through β1- and β2- integrins rescues chronic lymphocytic leukemia from spontaneous and drug-induced apoptosis and induces a peculiar gene expression profile on leukemic cells. 315
Lenalidomide interferes with tumor-promoting properties of nurse-like cells in chronic lymphocytic leukemia 315
Anticancer drug-loaded quantum dots engineered polymeric nanoparticles: Diagnosis/therapy combined approach 313
Dual inhibition of PI3K/mTOR signaling in chemoresistant AMLprimary cells. 312
Rhodotorula infection in haematological patient: risk factors and outcome 311
Human herpesvirus 6 latency characterized by high viral load: Chromosomal integration in many, but not all, cells 309
Missense mutations in the PML/RAR alpha ligand binding domain in ATRA-resistant As2O3 sensitive relapsed acute promyelocytic leukemia 309
Detection of circulating tumor cells by reverse transcriptase polymerase chain reaction of maspin in patients with breast cancer undergoing conventional-dose chemotherapy 309
T-cell large granular lymphocyte leukemia in solid organ transplant recipients: case series and review of the literature 309
Isolated extramedullary relapse after autologous bone marrow transplantation for acute myeloid leukemia: Case report and review of the literature 308
Angiogenesis in multiple myeloma: Correlation between in vitro endothelial colony growth (CFU-En) and clinical biological features 308
Organising pneumonia mimicking invasive fungal disease in patients with leukaemia. 307
Immunoglobulin gene mutations and frequent use of VH1-69 and VH4-34 segments in hepatitis C virus-positive and hepatitis C virus-negative nodal marginal zone B-cell lymphoma 305
Parvoviruses in blood donors and transplant patients, Italy 304
All-trans retinoic acid (ATRA) in non-promyelocytic acute myeloid leukemia (AML): results of combination of ATRA with low-dose Ara-C in three elderly patients with NPM1-mutated AML unfit for intensive chemotherapy and review of the literature 304
Absence of a directly causative role for human herpesvirus 7 in human lymphoma and a review of human herpesvirus 6 in human malignancy 303
A possible role for low-dose cyclosporine in refractory immune thrombocytopenic purpura. 303
Monoclonal Gammopathy of Undetermined Significance After Kidney Transplantation: Single-Center Experience 302
Chronic/relapsing lymphadenopathy associated with HHV-6B infection: a new benign clinico-pathologic entity occurring in immunocompetent individuals 302
The bone marrow represents an enrichment site of specific T lymphocytes against filamentous fungi 301
Cytarabine-related lung infiltrates on high resolution computerized tomography: a possible complication with benign outcome in leukemic patients. 300
Chronic and recurrent benign lymphadenopathy without constitutional symptoms associated with human herpesvirus-6B reactivation 296
Endothelium-mediated survival of leukemic cells and angiogenesis-related factors are affected by lenalidomide treatment in chronic lymphocytic leukemia 294
Nutlin-3 loaded nanocarriers: Preparation, characterization and in vitro antineoplastic effect against primary effusion lymphoma 294
Angiopoietin-2 acts as a survival factor for chronic lymphocytic leukemia B cells throughout Tie-2 receptor engagement 293
Herpes simplex virus pneumonia during standard induction chemotherapy for acute leukemia: case report and review of literature. 292
BCR-ABL-specific cytotoxic T cells in the bone marrow of patients with Ph(+) acute lymphoblastic leukemia during second-generation tyrosine-kinase inhibitor therapy. 292
3 CASES OF HUMAN HERPESVIRUS-6 LATENT INFECTION - INTEGRATION OF VIRAL GENOME IN PERIPHERAL-BLOOD MONONUCLEAR CELL-DNA 290
Macitentan, a double antagonist of endothelin receptors, efficiently impairs migration and microenvironmental survival signals in chronic lymphocytic leukemia 290
Human Herpesvirus 8 (HHV8) Infection and Related Diseases in Italian Transplant Cohorts. 290
Severe pancytopenia and hemophagocytosis after HHV-8 primary infection in a renal transplant patient successfully treated with foscarnet 288
invasive aspergillosis in patients with acute myeloid leukemia: SEIFEM-2008 registry study. 288
Clinical differences in sarcoidosis patients with and without lymphoma: a single-center retrospective cohort analysis. 288
Epstein-Barr virusassociated pneumonia in an adult patient with severe aplastic anaemia: resolutionafter the transient withdrawal of cyclosporine. 285
A non-chemotherapy treatment of a primary effusion lymphoma: durable remission after intracavitary cidofovir in HIV negative PEL refractory to chemotherapy 284
Inflammatory myofibroblastic tumor of the bone marrow. 283
Totale 34.496
Categoria #
all - tutte 413.690
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 413.690


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.250 0 0 0 0 0 0 0 0 0 0 634 616
2021/20227.626 429 921 761 423 209 387 457 379 811 560 1.263 1.026
2022/20237.922 981 833 575 700 1.066 1.089 168 789 949 127 338 307
2023/20245.851 204 312 371 497 1.142 482 643 885 124 177 336 678
2024/202518.358 667 248 297 1.282 3.087 2.584 1.353 976 2.315 1.045 2.018 2.486
2025/202633.278 2.595 1.667 3.532 3.952 5.107 2.757 4.475 1.906 3.499 3.208 580 0
Totale 105.140